Skip to main content
Top
Published in: Infection 1/2011

01-02-2011 | Case Report

Anti-interferon-γ autoantibody and opportunistic infections: case series and review of the literature

Authors: T. Kampitak, G. Suwanpimolkul, S. Browne, C. Suankratay

Published in: Infection | Issue 1/2011

Login to get access

Abstract

Immune defects in interleukin-12-dependent interferon-gamma (IFN-γ) pathways are associated with disseminated infections caused by non-tuberculous mycobacteria (NTM) and Salmonella. Recently, there have been an increasing number of reports of acquired autoantibodies to IFN-γ in adults, especially in Asian patients. We describe here three human immunodeficiency virus-negative Thai adults who had persistent or recurrent disseminated infections caused by NTM, Salmonella, and other opportunistic pathogens, possibly due to anti-IFN-γ autoantibodies. The antibodies were shown to exhibit very high inhibitory activity to IFN-γ. Two patients also developed Sweet’s syndrome during the course of infections. In addition, we also review all previous reports of patients with anti-IFN-γ antibodies who were susceptible to NTM and Salmonella infections.
Literature
1.
go back to reference Reichenbach J, Rosenzweig S, Doffinger R, Dupuis S, Holland SM, Casanova JL. Mycobacterial diseases in primary immunodeficiencies. Curr Opin Allergy Clin Immunol. 2001;1:503–11.PubMedCrossRef Reichenbach J, Rosenzweig S, Doffinger R, Dupuis S, Holland SM, Casanova JL. Mycobacterial diseases in primary immunodeficiencies. Curr Opin Allergy Clin Immunol. 2001;1:503–11.PubMedCrossRef
2.
go back to reference Doffinger R, Patel S, Kumararatne DS. Human immunodeficiencies that predispose to intracellular bacterial infections. Curr Opin Rheumatol. 2005;17:440–6.PubMedCrossRef Doffinger R, Patel S, Kumararatne DS. Human immunodeficiencies that predispose to intracellular bacterial infections. Curr Opin Rheumatol. 2005;17:440–6.PubMedCrossRef
3.
go back to reference Doffinger R, Dupuis S, Picard C, Fieschi C, Feinberg J, et al. Inherited disorders of IL-12 and IFNγ-mediated immunity: a molecular genetics update. Mol Immunol. 2002;38:903–9.PubMedCrossRef Doffinger R, Dupuis S, Picard C, Fieschi C, Feinberg J, et al. Inherited disorders of IL-12 and IFNγ-mediated immunity: a molecular genetics update. Mol Immunol. 2002;38:903–9.PubMedCrossRef
4.
go back to reference Patel SY, Doffinger R, Barcenas-Morales G, Kumararatne DS. Genetically determined susceptibility to mycobacterial infection. J Clin Pathol. 2008;61:1006–12.PubMedCrossRef Patel SY, Doffinger R, Barcenas-Morales G, Kumararatne DS. Genetically determined susceptibility to mycobacterial infection. J Clin Pathol. 2008;61:1006–12.PubMedCrossRef
5.
go back to reference Al-Muhsen S, Casanova JL. The genetic heterogeneity of Mendelian susceptibility to mycobacterial diseases. J Allergy Clin Immunol. 2008;122:1043–51.PubMedCrossRef Al-Muhsen S, Casanova JL. The genetic heterogeneity of Mendelian susceptibility to mycobacterial diseases. J Allergy Clin Immunol. 2008;122:1043–51.PubMedCrossRef
6.
go back to reference Alcais A, Abel L, Casanova JL. Human genetics of infectious diseases: between proof of principle and paradigm. J Clin Invest. 2009;119:2506–14.PubMedCrossRef Alcais A, Abel L, Casanova JL. Human genetics of infectious diseases: between proof of principle and paradigm. J Clin Invest. 2009;119:2506–14.PubMedCrossRef
7.
go back to reference Dorman SE, Picard C, Lammas D, Heyne K, van Dissel JT, Baretto R, et al. Clinical features of dominant and recessive interferon receptor 1 deficiencies. Lancet. 2004;364:2113–21.PubMedCrossRef Dorman SE, Picard C, Lammas D, Heyne K, van Dissel JT, Baretto R, et al. Clinical features of dominant and recessive interferon receptor 1 deficiencies. Lancet. 2004;364:2113–21.PubMedCrossRef
8.
go back to reference Phowthongkum P, Prasanthai V, Udomsantisook N, Suankratay C. Rapidly growing mycobacteria in King Chulalongkorn Memorial Hospital and review of the literature in Thailand. J Med Assoc Thai. 2005;88:1153–62.PubMed Phowthongkum P, Prasanthai V, Udomsantisook N, Suankratay C. Rapidly growing mycobacteria in King Chulalongkorn Memorial Hospital and review of the literature in Thailand. J Med Assoc Thai. 2005;88:1153–62.PubMed
9.
go back to reference Saritsiri S, Udomsantisook N, Suankratay C. Nontuberculous mycobacterial infections in King Chulalongkorn Memorial Hospital. J Med Assoc Thai. 2006;89:2035–46.PubMed Saritsiri S, Udomsantisook N, Suankratay C. Nontuberculous mycobacterial infections in King Chulalongkorn Memorial Hospital. J Med Assoc Thai. 2006;89:2035–46.PubMed
10.
go back to reference Chetchotisakd P, Kiertiburanakul S, Mootsikapun P, Assanasen S, Chaiwarith R, Anunnatsiri S. Disseminated nontuberculous mycobacterial infection in patients who are not infected with HIV in Thailand. Clin Infect Dis. 2007;45:421–7.PubMedCrossRef Chetchotisakd P, Kiertiburanakul S, Mootsikapun P, Assanasen S, Chaiwarith R, Anunnatsiri S. Disseminated nontuberculous mycobacterial infection in patients who are not infected with HIV in Thailand. Clin Infect Dis. 2007;45:421–7.PubMedCrossRef
11.
go back to reference Doffinger R, Helbert MR, Barcenas-Morales G, Yang K, Dupuis S, Ceron-Gutierrez C, et al. Autoantibodies to interferon-γ in a patient with selective susceptibility to mycobacterial infection and organ specific autoimmunity. Clin Infect Dis. 2004;38:e10–4.PubMedCrossRef Doffinger R, Helbert MR, Barcenas-Morales G, Yang K, Dupuis S, Ceron-Gutierrez C, et al. Autoantibodies to interferon-γ in a patient with selective susceptibility to mycobacterial infection and organ specific autoimmunity. Clin Infect Dis. 2004;38:e10–4.PubMedCrossRef
12.
go back to reference Hoflich C, Sabat R, Rosseau S, Temmesfeld B, Slevogt H, Docke WD, et al. Naturally occurring anti-IFN-γ autoantibody and severe infections with Mycobacterium chelonae and Burkholderia cocovenenans. Blood. 2004;103:673–5.PubMedCrossRef Hoflich C, Sabat R, Rosseau S, Temmesfeld B, Slevogt H, Docke WD, et al. Naturally occurring anti-IFN-γ autoantibody and severe infections with Mycobacterium chelonae and Burkholderia cocovenenans. Blood. 2004;103:673–5.PubMedCrossRef
13.
go back to reference Kampmann B, Hemingway C, Stephens A, Davidson R, Goodsall A, Anderson S, et al. Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-γ. J Clin Invest. 2005;115:2480–8.PubMedCrossRef Kampmann B, Hemingway C, Stephens A, Davidson R, Goodsall A, Anderson S, et al. Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-γ. J Clin Invest. 2005;115:2480–8.PubMedCrossRef
14.
go back to reference Patel SY, Ding L, Brown MR, Lantz L, Gay T, Cohen S, et al. Anti-IFN-γ autoantibodies in disseminated nontuberculous mycobacterial infections. J Immunol. 2005;175:4769–76.PubMed Patel SY, Ding L, Brown MR, Lantz L, Gay T, Cohen S, et al. Anti-IFN-γ autoantibodies in disseminated nontuberculous mycobacterial infections. J Immunol. 2005;175:4769–76.PubMed
15.
go back to reference Tanaka Y, Hori T, Ito K, Fujita T, Ishikawa T, Uchiyama T. Disseminated Mycobacterium avium complex infection in a patient with autoantibody to interferon-γ. Intern Med. 2007;46:1005–9.PubMedCrossRef Tanaka Y, Hori T, Ito K, Fujita T, Ishikawa T, Uchiyama T. Disseminated Mycobacterium avium complex infection in a patient with autoantibody to interferon-γ. Intern Med. 2007;46:1005–9.PubMedCrossRef
16.
go back to reference Koya T, Tsubata C, Kagamu H, Koyama K, Hayashi M, Kuwabara K, et al. Anti-interferon-γ autoantibody in a patient with disseminated Mycobacterium avium complex. J Infect Chemother. 2009;15:118–22.PubMedCrossRef Koya T, Tsubata C, Kagamu H, Koyama K, Hayashi M, Kuwabara K, et al. Anti-interferon-γ autoantibody in a patient with disseminated Mycobacterium avium complex. J Infect Chemother. 2009;15:118–22.PubMedCrossRef
17.
go back to reference Tufariello JM, Chan J, Flynn JL. Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect Dis. 2003;3:578–90.PubMedCrossRef Tufariello JM, Chan J, Flynn JL. Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect Dis. 2003;3:578–90.PubMedCrossRef
18.
go back to reference Cohen PR. Sweet’s syndrome—a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis. 2007;2:34.PubMedCrossRef Cohen PR. Sweet’s syndrome—a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis. 2007;2:34.PubMedCrossRef
19.
go back to reference Revoltella RP. Natural and therapeutically-induced antibodies to cytokines. Biotherapy. 1998;10:321–31.PubMedCrossRef Revoltella RP. Natural and therapeutically-induced antibodies to cytokines. Biotherapy. 1998;10:321–31.PubMedCrossRef
20.
go back to reference Vogel A, Strassburg CP, Obermayer-Straub P, Brabant G, Manns MP. The genetic background of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy and its autoimmune disease components. J Mol Med. 2002;80:201–11.PubMedCrossRef Vogel A, Strassburg CP, Obermayer-Straub P, Brabant G, Manns MP. The genetic background of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy and its autoimmune disease components. J Mol Med. 2002;80:201–11.PubMedCrossRef
21.
go back to reference Holland SM, Eisenstein EM, Kuhns DB, Turner ML, Fleisher TA, Strober W, Gallin JI, et al. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma: a preliminary report. N Engl J Med. 1994;330:1348–55.PubMedCrossRef Holland SM, Eisenstein EM, Kuhns DB, Turner ML, Fleisher TA, Strober W, Gallin JI, et al. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma: a preliminary report. N Engl J Med. 1994;330:1348–55.PubMedCrossRef
Metadata
Title
Anti-interferon-γ autoantibody and opportunistic infections: case series and review of the literature
Authors
T. Kampitak
G. Suwanpimolkul
S. Browne
C. Suankratay
Publication date
01-02-2011
Publisher
Springer-Verlag
Published in
Infection / Issue 1/2011
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-010-0067-3

Other articles of this Issue 1/2011

Infection 1/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.